Colesevelam now included in ACE/AACE guide as combination therapy for glycemic control
April 22, 2008
Bile sequestrant colesevelam now included in endocrinologist groups' diabetes guide.
The American College of Endocrinologists (ACE) and the American Association of Endocrinologists (AACE) have included colesevelam (Welchol, Daiichi Sankyo), a bile acid sequestrant, as an option for treating patients with Type 2 diabetes in their Road Maps to Achieve Glycemic Control in
